A study published in Aging and Disease shows the effectiveness of mesenchymal stem cell (MSC) therapy against a deadly immune reaction caused by COVID-19.
While scientists all over the world are working on a vaccine that would be effective against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 pandemic, a group of researchers from China and other countries has been exploring a therapeutic approach. Capitalizing on previous research, this group has conducted a successful trial of MSC therapy, resulting in the recovery of all seven patients [1]. These important results inspire hope, considering that a vaccine may still be more than a year away.
Comments are closed.